STTK - Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference | Benzinga
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that company management will participate in the 23rd Annual Needham Virtual Healthcare Conference being held virtually from April 8-11, 2024.
Presentation Details
Conference: 23rd Annual Needham Virtual Healthcare Conference
Format: Fireside chat with covering analyst Gil Blum, Ph.D.
Presenter: Dr. ...